Canada · Health Canada Drug Product Database

MYLAN-NIFEDIPINE EXTENDED RELEASE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 96017
DIN: 02471078
Form: Tablet (Extended-Release)
Company as listed by source: MYLAN PHARMACEUTICALS ULC
Source status: Cancelled Pre Market (2021-06-08)
Source last updated: 2025-03-22

Source-listed ingredients

NIFEDIPINE — 20 MG

These values do not establish equivalence or a dose recommendation.

Packages

30/100/3x10

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →